References
- Association of the British Pharmaceutical Industry. Guidelines on Good Clinical Research Practice. ABPI, London 19881. Association of the British Pharmaceutical Industry. Guidelines on Good Clinical Research Practice. ABPI, London 1988
- Bergmann V. H., Tabassi D., Rasser W., Necek St., Pittner H. The influence of the new beta-adrenergic blocking agent celiprolol on circulatory effects of isoproterenol in healthy volunteers. Arzneim. Forsch. 1983; 33: 53, 552. Bergmann V. H., Tabassi D., Rasser W., Necek St., Pittner H. The influence of the new beta-adrenergic blocking agent celiprolol on circulatory effects of isoproterenol in healthy volunteers. Arzneim. Forsch. 1983; 33: 53, 55
- Brown R., Slutsky A., Doshan H. D., Applin W. J., Caruso S. S., Neiss E. S. The effect of celiprolol, a bronchosparing cardioselective beta1-, alpha2-adrenoreceptor blocking agent in asthma. Circulation 1984; 70: 382, Suppl. II3. Brown R., Slutsky A., Doshan H. D., Applin W. J., Caruso S. S., Neiss E. S. The effect of celiprolol, a bronchosparing cardioselective beta1-, alpha2-adrenoreceptor blocking agent in asthma. Circulation 1984; 70: 382, Suppl. II
- Capone P., Mayol R. A comparative study of celiprolol and placebo in the treatment of hypertension. Br. J. Clin. Pract. 1985; 39: 65–69, Suppl. 404. Capone P., Mayol R. A comparative study of celiprolol and placebo in the treatment of hypertension. Br. J. Clin. Pract. 1985; 39: 65–69, Suppl. 40
- Capone P., Mayol R., Matthieu M. A comparative study of celiprolol and chlorthalidone in hypertensive patients with reversible airways obstruction. Br J. Clin. Pract. 1985; 39: 37–40, Suppl. 405. Capone P., Mayol R., Matthieu M. A comparative study of celiprolol and chlorthalidone in hypertensive patients with reversible airways obstruction. Br J. Clin. Pract. 1985; 39: 37–40, Suppl. 40
- Hoffmann W., Hoffmann H. Results of the Austrian celiprolol postmarketing study. J. Cardiovasc. Pharmacol. 1986; 8: S88–S90, Suppl. 46. Hoffmann W., Hoffmann H. Results of the Austrian celiprolol postmarketing study. J. Cardiovasc. Pharmacol. 1986; 8: S88–S90, Suppl. 4
- Matthys H., Doshan H. D., Ruhle K.-H., Applin W. J., Braig H., Pohl M. Bronchosparing properties of celiprolol, a new beta., alpha1-blocker2 in propranolol-sensitive asthmatic patients. /. Cardiovasc. Pharmacol. 1986; 8: S40–S42, Suppl. 47. Matthys H., Doshan H. D., Ruhle K.-H., Applin W. J., Braig H., Pohl M. Bronchosparing properties of celiprolol, a new beta., alpha1-blocker2 in propranolol-sensitive asthmatic patients. /. Cardiovasc. Pharmacol. 1986; 8: S40–S42, Suppl. 4
- Pittner H. Pharmacodynamic effects of celiprolol, a cardioselective beta-receptor blocker. Arzneim. Forsch. 1983; 33: 13, 258. Pittner H. Pharmacodynamic effects of celiprolol, a cardioselective beta-receptor blocker. Arzneim. Forsch. 1983; 33: 13, 25
- Prichard B. N. C., Gillam P. M. S. Use of propranolol (Inderal) in the treatment of hypertension. Br. Med. J. 1964; 2: 725, 7279. Prichard B. N. C., Gillam P. M. S. Use of propranolol (Inderal) in the treatment of hypertension. Br. Med. J. 1964; 2: 725, 727
- Pruss T. P., Khandwala A., Wolf P. S., Grebow P., Wong I. Celiprolol: a new beta-adrenoceptor antagonist with novel ancillary properties. J. Curdiovasc. Pharmacol. 1986; 8: S29–S32, Suppl. 410. Pruss T. P., Khandwala A., Wolf P. S., Grebow P., Wong I. Celiprolol: a new beta-adrenoceptor antagonist with novel ancillary properties. J. Curdiovasc. Pharmacol. 1986; 8: S29–S32, Suppl. 4
- Pruss T. P., Lamon K. D., Hagen N. S. Celiprolol - overview of 6 years of clinical trials experience. /. Int. Med. Rex 1988; 16: 17A–22A, Suppl. 111. Pruss T. P., Lamon K. D., Hagen N. S. Celiprolol - overview of 6 years of clinical trials experience. /. Int. Med. Rex 1988; 16: 17A–22A, Suppl. 1
- Taylor S. H., Beattie A., Silke B. Celiprolol in the treatment of hypertension: a comparison of propranolol./. Cardiovasc. Pharmacol. 1986; 8: S127–S131, Suppl. 412. Taylor S. H., Beattie A., Silke B. Celiprolol in the treatment of hypertension: a comparison of propranolol./. Cardiovasc. Pharmacol. 1986; 8: S127–S131, Suppl. 4
- Wolf P. S., Smith R. D., Khandwala A., Van Inwegen R. G., Gordon R. J., Mann W. S., Romano D. V., Pruss T. P. Celiprolol–pharmacological profile of an unconventional beta-blocker. Br J. Clin. Pract. 1985; 39: 5–11, Suppl. 4013. Wolf P. S., Smith R. D., Khandwala A., Van Inwegen R. G., Gordon R. J., Mann W. S., Romano D. V., Pruss T. P. Celiprolol–pharmacological profile of an unconventional beta-blocker. Br J. Clin. Pract. 1985; 39: 5–11, Suppl. 40